AMDL to Present at Brookstreet Securities Conference; Focusing on the Company's China Operations
May 03 2007 - 10:47AM
PR Newswire (US)
TUSTIN, Calif., May 3 /PRNewswire-FirstCall/ -- AMDL, Inc.
(AMEX:ADL), headquartered in Tustin, California, with operations in
Shenzhen, Jiangxi and Jilin China through its wholly owned
subsidiary Jade Pharmaceutical Inc., today announced that its CEO,
Gary Dreher, will present at the 2007 Brookstreet Securities
Corporation Annual Conference May 16-20 at the Hyatt Regency Resort
in Huntington Beach, California. Mr. Dreher will tell the
Brookstreet investment professionals about recent successes for the
Company in China, including the introduction of Ondansetron
Hydrochloride, with $2 billion in sales worldwide in 2006, for
nausea caused by chemotherapy, radiation and other conditions, and
the newly licensed Chinese products Lomefloxacin Aspartate and
Levofloxacin, broad spectrum antibiotics, which have worldwide
sales of more than $4.8 billion last year. "Jade Pharmaceuticals
has access to the fastest growing pharmaceutical and consumer
market in the world: China. Jade currently manufactures large
volume injection fluids, tablets and other related products,
holding licenses for 133 products. It also manufactures generic,
over the counter and supplemental pharmaceutical products under
certified Chinese Good Manufacturing Practice standards and we are
anxious to tell these investors about Jade Pharmaceuticals'
achievements," Mr. Dreher said. Brookstreet Securities is a
full-service, national network of investment professionals
dedicated to serving the needs of sophisticated investors. Its
annual conference is an excellent forum for companies to share
their achievements and business strategies with these top brokers.
For more information on AMDL, visit http://www.amdl.com/ .
Forward-Looking Statements: This news release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such statements are
subject to certain risks and uncertainties, and actual
circumstances, events or results may differ materially from those
projected in such forward-looking statements. The Company cautions
readers not to place undue reliance on any forward-looking
statements. The Company does not undertake, and specifically
disclaims any obligation, to update or revise such statements to
reflect new circumstances or unanticipated events as they occur.
Contact: AMDL, Inc. Gary L. Dreher President & CEO (714)
505-4460 DATASOURCE: AMDL, Inc. CONTACT: Gary L. Dreher, President
& CEO of AMDL, Inc., +1-714-505-4460 Web site:
http://www.amdl.com/
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From May 2024 to Jun 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2023 to Jun 2024